Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CardioPostCovid Study: Cardiovascular Consequences After COVID-19

NCT04452630 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT04452630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CardioPostCovid Study: Cardiovascular Consequences After COVID-19
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Observational
Overall status
Terminated
Start date
June 23, 2020
Completion date
February 1, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular consequences after an episode of covid 19